As of this morning, providers on our platform can now send prescriptions for Zepbound® vials and KwikPen®, as well as Foundayo™, to the LillyDirect® pharmacy and access self-pay pricing for our customers because of an expansion in our platform’s functionality.
In many ways, today reminds me of Netflix’s early days, when everyone talked about whether they would have the latest blockbuster in their catalog. As if Netflix’s success depended on its ability to become the distribution channel for a single film.
They were missing the forest for the trees: Netflix wasn’t just renting DVDs. It was changing consumer behavior by ruthlessly prioritizing choice and inventing new pathways to the things people wanted the most.
By offering a full range of FDA-approved GLP-1s on our platform, we’re similarly giving our customers more choices through all the tools we have available – and we’ll continue to push here on behalf of everyone who depends on us for their care.
Read more on how we’re making this possible, including important info, here:
https://t.co/HxYN1KhGwS
Ok, so I was going to sell 300 puts in $HIMS but I feel like there is more upside in buying shares. Just got a starter position with 15,000 shares pre market. I may add on dips. But I’m happy with this.
I was one of the old $HIMS bulls who sold a while back. I gotta admit, they completely flipped the script. Turning the $NVO lawsuit into a partnership, and now peptides on the horizon. Market cap only $6B. Peptide TAM is huge, only need a slice of it. Markets are forward looking, the risk associated with this has diminished. The upside has increased. $HIMS is in better shape now at $26 than it was in October in the $60s. I don’t see how this isn’t a minimum double by January.
Props to the bulls that never lost hope. I’m not in that category, but I did buy $NBIS in the $40s after I left ;-) 🙏.
Regardless, I’m back. Let’s ride!!! 😎
We founded Hims & Hers to help more people feel great. To disrupt a broken healthcare system and create a new model of health where innovators work together to deliver access to care that actually serves everyday people.
We align how we operate with where we see major growth opportunities and in a way that allows us to meet our customers where they are (and where they want to go). That’s why, later this month, Hims & Hers customers will have access to FDA-approved medications from @novonordisk as a part of a strategic collaboration.
The weight loss landscape is completely different today than it was when we first entered the category. FDA-approved GLP-1 treatments are now more accessible, with greater affordability and more flexible dosing options and form factors. These market changes are shifting consumer demand towards these branded medications.
We’re moving our model forward another step with this strategic shift in our US weight loss business. This evolution will make us the largest global consumer health platform providing access to more affordable, approved medications.
We will continue to innovate across our platform, keeping what’s best for consumers as our North Star. There's challenging, important work in front of us, and I've never been more excited about the path ahead. Just like we always do, Hims & Hers will rise to meet the moment.
More here: https://t.co/jcWkrvvkts
Important info here: https://t.co/WiCHFnUnN2
Are y’all understanding that these ppl have been sacrificing children as a way of gaining & maintaining power? If you ever vote DemonCrat again, you’re just as soulless as they are & will perish. Maybe it’s time for me to do some story times — since I was trying to not say what I know — yet they continue to attempt bullying.
Also, I won’t be releasing an album until my contract is renegotiated & until I tell you about all the sabotage this RICO is finding out about Billboard.
Your favorite artist has been practicing rituals in a satanic cult where they take babies from other countries & mutilate & kill them as a form of a blood sacrifice to their God. You see, when your master is satan, you must constantly shed blood. However, the JIG IS UP.
You probably missed Tesla (and the generational wealth), so don't repeat the same mistake twice.
WeRide $WRD has close to the scale of Waymo, with superior L4 tech, but trades below 1% of its valuation because it,'s Chinese.
Watch this video and learn👇
https://t.co/KmDuAiWyOn
American investors can’t grasp the level of innovation taking place in Asia with respect to robotics and in particular autonomous driving.
It’s alot of disbelief so they fud the stocks because all they see in SF are robotaxis with safety drivers. That’s the alpha.
I’m long $WRD